A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma
Clinical trial NCT06424626 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06424626
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-28
- Primary completion
- 2027-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.